Found 15 matching trials
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067) PHASE3 This is a 12-Week clinical trial in patients with Primary hypercholesterole...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118) PHASE3 This study is being done to find out if tablets containing extended release...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) PHASE3 This is a 12-week clinical trial in lipid clinic patients for whom niacin t...
Show More Location
Multiple Locations
Learn More & Join Trial
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) PHASE3 This is a 12-week clinical trial in participants with mixed hyperlipidemia ...
Show More Location
Multiple Locations
Learn More & Join Trial
MK-0524B Lipid Study (MK-0524B-063) PHASE3 This is a 20-week clinical trial in participants with primary hypercholeste...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133) PHASE3 This is a multicenter, randomized, double-blind, placebo-controlled study i...
Show More Location
Multiple Locations
Learn More & Join Trial
MK0524A Bioequivalence Study (0524A-059) PHASE1 This study will evaluate the definitive bioequivalence of tablets of MK0524...
Show More Location
Multiple Locations
Learn More & Join Trial
Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082) PHASE3 The purpose of this study is to test the effect of MK0524A (niacin (+) laro...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED) PHASE1 This is a 3-period study. Periods 1 and 2 will evaluate the effects of mult...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158) PHASE1 The purpose of this study is to determine the pharmacokinetics of laropipra...
Show More Location
Multiple Locations
Learn More & Join Trial